1. 2021
  2. Readily available biomarkers predict poor survival in metastatic pancreatic cancer

    Dutch Pancreatic Cancer Group, 2021, In: Biomarkers. 26, 4, p. 325-334 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Stroma-targeting treatment for patients with elevated adam12 levels

    Bijlsma, M. F. & van Laarhoven, H. W. M., 2021, Patent No. US Patent App. 16/685,100

    Research output: PatentProfessional

  4. Systems biology and molecular characterization of subtypes to guide targeted therapies in gastric cancer

    Dings, M. P. G., Vermeulen, L. & Bijlsma, M. F., 2021, Research and Clinical Applications of Targeting Gastric Neoplasms. p. 259-288

    Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

  5. Tumor-immune landscape patterns before and after chemoradiation in resectable esophageal adenocarcinomas

    Soeratram, T. T., Creemers, A., Meijer, S. L., de Boer, O. J., Vos, W., Hooijer, G. K., van Berge Henegouwen, M. I., Hulshof, M. C., Bergman, J. J., Lei, M., Bijlsma, M. F., Ylstra, B., van Grieken, N. C. & van Laarhoven, H. W., 2021, (E-pub ahead of print) In: Journal of pathology. 256, 3, p. 282-296

    Research output: Contribution to journalArticleAcademicpeer-review

  6. 2020
  7. Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers

    Mantini, G., Vallés, A. M., le Large, T. Y. S., Capula, M., Funel, N., Pham, T. V., Piersma, S. R., Kazemier, G., Bijlsma, M. F., Giovannetti, E. & Jimenez, C. R., Dec 2020, In: Cellular oncology. 43, 6, p. 1147-1159 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion

    Tekin, C., Aberson, H. L., Bijlsma, M. F. & Spek, C. A., Dec 2020, In: BMC cancer. 20, 1, 1183.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation

    Tekin, C., Aberson, H. L., Waasdorp, C., Hooijer, G. K. J., de Boer, O. J., Dijk, F., Bijlsma, M. F. & Spek, C. A., Dec 2020, In: Cellular oncology. 43, 6, p. 1161-1174 14 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Ccaat/enhancer-binding protein delta (C/ebpδ): A previously unrecognized tumor suppressor that limits the oncogenic potential of pancreatic ductal adenocarcinoma cells

    Hartl, L., Duitman, J., Aberson, H. L., Chen, K., Dijk, F., Roelofs, J. J. T. H., Dings, M. P. G., Hooijer, G. K. J., Hernanda, P. Y., Pan, Q., Busch, O. R., Besselink, M. G. H., Boerman, T., Peppelenbosch, M. P., Bijlsma, M. F. & Spek, C. A., 1 Sept 2020, In: Cancers. 12, 9, p. 1-21 21 p., 2546.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...14 Next

ID: 41996